Discovery Grant Review Panels

Note: Panel lists will be updated as panel members are recruited.


Four panels of experts will review the applications submitted:

Panel A: Biology of Prostate Cancer
Studies that will develop new knowledge to improve our understanding of the biology of prostate cancer may include prostate cancer initiation (gene expression, oncogenes), tumour progression and metastasis.
 
Amina Zoubeidi
Chair
University of British Columbia
Vancouver, BC
Steve Bilodeau
 
Université Laval
Quebec, QC
Xuesen Dong
 
University of British Columbia
Vancouver, BC
Madhuri Koti
 
Queen's University
Kingston, ON
Adam Sowalsky
 
National Institutes of Health
Bethesda, MD, USA
Jose Teodoro
 
McGill University
Montreal, QC
George Yousef
 
St Michael's Hospital
Toronto, ON
Samer Hussein
Scientific Officer
Université Laval
Quebec, QC
Jo-Anne Phillips
Community Representative
Irishtown, NB
Note: This list will be updated as panel members are recruited.


Panel B: Early Detection of Prostate Cancer
Research that aims to identify, develop and test novel prostate cancer markers and imaging methods that are helpful in detecting and/or diagnosing cancer as well as predicting the outcome or chance of recurrence.
 
Glenn Bauman
Chair
London Regional Cancer Program
London, ON
Michelle Downes
 
Sunnybrook Health Sciences Centre
Toronto, ON
Housheng He
 
University Health Network
Toronto, ON
Farzad Khalvati
 
Sunnybrook Research Institute
Toronto, ON
Claudia Kleinman
 
Lady Davis Institute for Medical Research
Montreal, QC
Vincent Bouvet
Scientific Officer
Memorial University of Newfoundland
St John's, NL
David Labbé
Scientific Officer
McGill University
Montreal, QC
Bill Sutherland
Community Representative
Victoria, BC
Ted Wheatley
Community Representative
Toronto, ON
Note: This list will be updated as panel members are recruited.


Panel C: Experimental Therapeutics
This panel will review applications in the area of the discovery and development of new anti-prostate cancer treatments and includes chemotherapy, hormone therapy, radiation therapy and surgery.
 
Bernie Eigl
Chair
BC Cancer
Vancouver, BC
Brandon Bernard
 
University of Colorado
Denver, CO, USA
Warren Chan
 
University of Toronto
Toronto, ON
Nawaid Usmani
 
University of Alberta
Edmonton, AB
Humphrey Fonge
Scientific Officer
University of Saskatchewan
Saskatoon, SK
Jean-Michel Lavoie
Scientific Officer
BC Cancer
Vancouver, BC
Thomas Maxwell
Community Representative
Victoria, BC
Note: This list will be updated as panel members are recruited.


Panel D: Health systems, services, population and public health
Applications reviewed by this panel will include those studying interventions at the population level, with patients, survivors or other cohorts; epidemiological studies; research into the quality of life of those affected by prostate cancer; novel research to understand the etiology of prostate cancer; health services research related to prostate cancer.
 
Michael Leveridge
Chair
Queen's University
Kingston, ON
Jennifer Jones
 
University Health Network
Toronto, ON
Corinne Joshu
 
Johns Hopkins University
Baltimore, MD, USA
Julian Kim
 
CancerCare Manitoba
Winnipeg, MB
Salaheddin Mahmud
 
University of Manitoba
Winnipeg, MB
Sheila Garland
Scientific Officer
Memorial University of Newfoundland
St John's, NL
Kel Keen
Community Representative
Edmonton, AB
Maryann Istiloglu
Community Representative
Toronto, ON
Note: This list will be updated as panel members are recruited.

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive